The SNP rs1432679 in the EBF1 gene reduced the risk of \ PR- BC risk (OR = 0.715, 95% CI, 0.553 - 0.925, p = 0.010) and in the codominant model (OR of 0.52 (0.28–0.96), p = 0.047) for the genotype T/T (Supplementary Table S8), as well as in the dominant model (OR of 0.68 (0.48–0.95), p = 0.026 ) for the genotype T/C -T/T and the log-additive model (OR of 0.72 (0.56–0.94), p = 0.014). The gene discussed is EBF1; the disease is breast cancer.